JP2020037574A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020037574A5 JP2020037574A5 JP2019202439A JP2019202439A JP2020037574A5 JP 2020037574 A5 JP2020037574 A5 JP 2020037574A5 JP 2019202439 A JP2019202439 A JP 2019202439A JP 2019202439 A JP2019202439 A JP 2019202439A JP 2020037574 A5 JP2020037574 A5 JP 2020037574A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- peg
- acid
- group
- poloxamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 15
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 9
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 9
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 9
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 9
- 229920001577 copolymer Polymers 0.000 claims 7
- 208000002193 Pain Diseases 0.000 claims 6
- 239000002202 Polyethylene glycol Substances 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- HHEHWCIYDICHCG-ODZAUARKSA-N (z)-but-2-enedioic acid;methoxyethene Chemical compound COC=C.OC(=O)\C=C/C(O)=O HHEHWCIYDICHCG-ODZAUARKSA-N 0.000 claims 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 4
- 239000003960 organic solvent Substances 0.000 claims 4
- 229920005862 polyol Polymers 0.000 claims 4
- 150000003077 polyols Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical class FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 239000005642 Oleic acid Substances 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 229960002725 isoflurane Drugs 0.000 claims 3
- 150000005677 organic carbonates Chemical class 0.000 claims 3
- 229920001983 poloxamer Polymers 0.000 claims 3
- 229960000502 poloxamer Drugs 0.000 claims 3
- 229920001993 poloxamer 188 Polymers 0.000 claims 3
- 229940044519 poloxamer 188 Drugs 0.000 claims 3
- 229920001992 poloxamer 407 Polymers 0.000 claims 3
- 229940044476 poloxamer 407 Drugs 0.000 claims 3
- 229920001451 polypropylene glycol Polymers 0.000 claims 3
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 claims 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 2
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 claims 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims 2
- 229940081974 saccharin Drugs 0.000 claims 2
- 235000019204 saccharin Nutrition 0.000 claims 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 claims 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 claims 1
- 235000021357 Behenic acid Nutrition 0.000 claims 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 claims 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 claims 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims 1
- 239000005639 Lauric acid Substances 0.000 claims 1
- 235000021353 Lignoceric acid Nutrition 0.000 claims 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 claims 1
- 235000021314 Palmitic acid Nutrition 0.000 claims 1
- 235000021319 Palmitoleic acid Nutrition 0.000 claims 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 claims 1
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 claims 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims 1
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims 1
- DUFKCOQISQKSAV-UHFFFAOYSA-N Polypropylene glycol (m w 1,200-3,000) Chemical compound CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 claims 1
- 235000021322 Vaccenic acid Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 1
- 229940114079 arachidonic acid Drugs 0.000 claims 1
- 235000021342 arachidonic acid Nutrition 0.000 claims 1
- 229940116226 behenic acid Drugs 0.000 claims 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims 1
- DPYMFVXJLLWWEU-UHFFFAOYSA-N desflurane Chemical class FC(F)OC(F)C(F)(F)F DPYMFVXJLLWWEU-UHFFFAOYSA-N 0.000 claims 1
- 229960003537 desflurane Drugs 0.000 claims 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 1
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical class FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 claims 1
- 229960000305 enflurane Drugs 0.000 claims 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 claims 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- -1 halide compound Chemical class 0.000 claims 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical class FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 claims 1
- 229960003132 halothane Drugs 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007913 intrathecal administration Methods 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- OYHQOLUKZRVURQ-AVQMFFATSA-N linoelaidic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 claims 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 1
- 229960004488 linolenic acid Drugs 0.000 claims 1
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 claims 1
- 229960002455 methoxyflurane Drugs 0.000 claims 1
- 230000007659 motor function Effects 0.000 claims 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229960002446 octanoic acid Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 claims 1
- DFEYYRMXOJXZRJ-UHFFFAOYSA-N sevoflurane Chemical class FCOC(C(F)(F)F)C(F)(F)F DFEYYRMXOJXZRJ-UHFFFAOYSA-N 0.000 claims 1
- 229960002078 sevoflurane Drugs 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims 1
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021213648A JP7410114B2 (ja) | 2013-03-15 | 2021-12-28 | 新規な鎮痛組成物 |
| JP2023215692A JP2024026453A (ja) | 2013-03-15 | 2023-12-21 | 新規な鎮痛組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361792383P | 2013-03-15 | 2013-03-15 | |
| US61/792,383 | 2013-03-15 | ||
| US201361814485P | 2013-04-22 | 2013-04-22 | |
| US61/814,485 | 2013-04-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502723A Division JP6669645B2 (ja) | 2013-03-15 | 2014-03-14 | 新規な鎮痛組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021213648A Division JP7410114B2 (ja) | 2013-03-15 | 2021-12-28 | 新規な鎮痛組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020037574A JP2020037574A (ja) | 2020-03-12 |
| JP2020037574A5 true JP2020037574A5 (https=) | 2020-04-23 |
Family
ID=51538291
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502723A Active JP6669645B2 (ja) | 2013-03-15 | 2014-03-14 | 新規な鎮痛組成物 |
| JP2019202439A Pending JP2020037574A (ja) | 2013-03-15 | 2019-11-07 | 新規な鎮痛組成物 |
| JP2021213648A Active JP7410114B2 (ja) | 2013-03-15 | 2021-12-28 | 新規な鎮痛組成物 |
| JP2023215692A Pending JP2024026453A (ja) | 2013-03-15 | 2023-12-21 | 新規な鎮痛組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502723A Active JP6669645B2 (ja) | 2013-03-15 | 2014-03-14 | 新規な鎮痛組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021213648A Active JP7410114B2 (ja) | 2013-03-15 | 2021-12-28 | 新規な鎮痛組成物 |
| JP2023215692A Pending JP2024026453A (ja) | 2013-03-15 | 2023-12-21 | 新規な鎮痛組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US9655867B2 (https=) |
| EP (2) | EP2968214B1 (https=) |
| JP (4) | JP6669645B2 (https=) |
| CN (3) | CN113712911A (https=) |
| AU (4) | AU2014227996B2 (https=) |
| CA (2) | CA2906072C (https=) |
| DK (1) | DK2968214T3 (https=) |
| ES (1) | ES2873964T3 (https=) |
| PL (1) | PL2968214T3 (https=) |
| WO (1) | WO2014143964A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2968214T3 (pl) * | 2013-03-15 | 2021-11-02 | Newvapogen, Inc. | Nowe kompozycje przeciwbólowe |
| CA2955229C (en) * | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| EP3325062A4 (en) | 2015-07-20 | 2019-03-13 | Medical Developments International Limited | INHALER FOR INHALABLE LIQUIDS |
| WO2017011867A1 (en) | 2015-07-20 | 2017-01-26 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| WO2017011865A1 (en) | 2015-07-20 | 2017-01-26 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| US9554998B1 (en) | 2015-08-04 | 2017-01-31 | Damaso Fernandez Gines | Composition of analgesic bioadhesive healing microspheres |
| CA3019582A1 (en) | 2016-03-31 | 2017-10-05 | Smartech Topical, Inc. | Delivery system |
| AU2017325107B2 (en) | 2016-09-06 | 2022-10-06 | Medical Developments International Limited | Inhaler device for inhalable liquids |
| GB201706969D0 (en) * | 2017-05-02 | 2017-06-14 | Medherant Ltd | Formulation |
| CN107693560A (zh) * | 2017-09-13 | 2018-02-16 | 冯威 | 一种具有镇痛功能的药学组合物 |
| US11446237B2 (en) * | 2019-03-08 | 2022-09-20 | Taro Pharmaceutical Industries Ltd. | Stable topical compositions of fenoldopam |
| CN110090197A (zh) * | 2019-04-19 | 2019-08-06 | 广州芮一生物科技有限公司 | 一种可成膜的麻醉面膜膏 |
| US20220347132A1 (en) * | 2019-09-19 | 2022-11-03 | Celista Pharmaceuticals Llc | Sprayable liquid lidocaine solution |
| JP7515582B2 (ja) * | 2019-11-06 | 2024-07-12 | スマーテック トピカル，インコーポレイテッド | シクロオキシゲナーゼ阻害剤の局所配合剤およびその使用 |
| WO2021134029A1 (en) * | 2019-12-24 | 2021-07-01 | Ampersand Biopharmaceuticals, Inc. | Topical nicotine for smoking cessation |
| EP4103151A1 (en) * | 2020-02-11 | 2022-12-21 | Taro Pharmaceutical Industries Ltd. | Compositions comprising desoximetasone and tazarotene |
| EP4333826A4 (en) * | 2021-05-05 | 2025-03-12 | Smartech Topical, Inc. | TOPICAL NAPROXEN FORMULATIONS AND THEIR USES |
| CN113289172B (zh) * | 2021-05-31 | 2023-11-03 | 成都中医药大学附属医院 | 用于治疗急诊创伤性疼痛的芳香化甲氧氟烷吸入装置 |
| EP4522112A1 (en) | 2022-05-13 | 2025-03-19 | Laboratorios Gebro Pharma, S.A. | Pharmaceutical composition for topical administration comprising a volatile anaesthetic |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3216897A (en) * | 1961-11-02 | 1965-11-09 | Air Reduction | Injectable anesthetic |
| AR206458A1 (es) | 1975-03-17 | 1976-07-23 | Minnesota Mining & Mfg | Materiales de hoja termograficas y fototermograficas |
| US4725442A (en) | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
| US4622219A (en) | 1983-06-17 | 1986-11-11 | Haynes Duncan H | Method of inducing local anesthesia using microdroplets of a general anesthetic |
| JPS62281814A (ja) * | 1986-05-27 | 1987-12-07 | Teisan Seiyaku Kk | 徐放化貼付剤 |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5091188A (en) | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| US5114715A (en) | 1990-11-29 | 1992-05-19 | Sepracor Inc. | Methods of use and compositions of (s)-isoflurane and (s)-desflurane |
| US5114714A (en) | 1990-11-29 | 1992-05-19 | Sepracor, Inc. | Methods of use and compositions of (r)-isoflurane and (r)-desflurane |
| US5120561A (en) | 1991-04-25 | 1992-06-09 | American Lecithin Company | Food composition and method |
| US5283372A (en) | 1991-12-04 | 1994-02-01 | Anaquest, Inc. | Preparation of purified optical isomers of desflurane |
| US6007838A (en) | 1995-06-07 | 1999-12-28 | The United States Of America As Represented By The Secretary Of The Army | Process for making liposome preparation |
| US20030185761A1 (en) | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| GB2350297A (en) * | 1999-05-27 | 2000-11-29 | Abbott Lab | Injectable halogenated anesthetic formulation in emulsion form |
| CA2500310C (en) | 2002-10-11 | 2013-03-12 | Baxter International, Inc. | Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| ATE365034T1 (de) | 2003-09-10 | 2007-07-15 | Cristalia Prod Quimicos Farm | Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung |
| US20050079147A1 (en) | 2003-10-14 | 2005-04-14 | Bernard Delaey | Wound healing compositions and uses |
| CA2663857C (en) * | 2006-09-20 | 2017-10-31 | The Board Of Regents Of The University Of Texas System | Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| CN101522180A (zh) * | 2006-09-20 | 2009-09-02 | 得克萨斯大学体系董事会 | 用于区域麻醉和/和疼痛缓解的递送挥发性麻醉剂的方法 |
| JP2008288365A (ja) * | 2007-05-17 | 2008-11-27 | Mitsubishi Electric Corp | 半導体装置 |
| EP2244783B1 (en) * | 2008-01-22 | 2019-12-18 | Board Of Regents, The University Of Texas System | Volatile anesthetic compositions and methods of use |
| PL2244737T3 (pl) * | 2008-01-22 | 2020-05-18 | The Board Of Regents Of The University Of Texas System | Kompozycje lotnego środka znieczulającego zawierające rozpuszczalniki ekstrakcyjne do znieczulania miejscowego i / albo zwalczania bólu |
| US7736537B1 (en) * | 2008-01-24 | 2010-06-15 | Mainstream Engineering Corp. | Replacement solvents having improved properties for refrigeration flushes |
| WO2009117489A1 (en) | 2008-03-18 | 2009-09-24 | Dr. Reddy's Laboratories Ltd. | Dexlansoprazole process and polymorphs |
| US8193232B2 (en) * | 2009-02-13 | 2012-06-05 | Topica Pharmaceuticals, Inc. | Anti-fungal formulation |
| WO2010112974A2 (en) * | 2009-03-31 | 2010-10-07 | Freescale Semiconductor, Inc. | System for tree sequence testing of a device and method for tree sequence testing of a device in a test framework architecture |
| CN109394689A (zh) * | 2009-05-05 | 2019-03-01 | 德州大学系统董事会 | 挥发性麻醉剂的新型制剂及其用于减轻炎症的使用方法 |
| US8498853B2 (en) * | 2009-07-20 | 2013-07-30 | Exxonmobil Upstream Research Company | Petrophysical method for predicting plastic mechanical properties in rock formations |
| CN101791291B (zh) * | 2010-04-02 | 2011-12-28 | 徐州医学院 | 七氟醚静脉微乳剂及其制备方法 |
| EP2723325A4 (en) * | 2011-06-24 | 2015-03-11 | Vapogenix Inc | NEW FORMULATIONS AND METHODS FOR TREATING DERMATOLOGICAL DISORDERS OR DISEASES |
| RU2013155713A (ru) * | 2011-07-06 | 2015-08-20 | Профибрикс Бв | Составы для лечения ран |
| WO2013016511A1 (en) * | 2011-07-27 | 2013-01-31 | University Of Miami | Stable liquid formulations of volatile gas anesthetics |
| PL2968214T3 (pl) * | 2013-03-15 | 2021-11-02 | Newvapogen, Inc. | Nowe kompozycje przeciwbólowe |
-
2014
- 2014-03-14 PL PL14762748T patent/PL2968214T3/pl unknown
- 2014-03-14 AU AU2014227996A patent/AU2014227996B2/en active Active
- 2014-03-14 CN CN202110953055.4A patent/CN113712911A/zh active Pending
- 2014-03-14 EP EP14762748.3A patent/EP2968214B1/en active Active
- 2014-03-14 EP EP21161625.5A patent/EP3854389A1/en active Pending
- 2014-03-14 CN CN202110196601.4A patent/CN112933036A/zh active Pending
- 2014-03-14 DK DK14762748.3T patent/DK2968214T3/da active
- 2014-03-14 JP JP2016502723A patent/JP6669645B2/ja active Active
- 2014-03-14 ES ES14762748T patent/ES2873964T3/es active Active
- 2014-03-14 CA CA2906072A patent/CA2906072C/en active Active
- 2014-03-14 CN CN201480040037.5A patent/CN105611921A/zh active Pending
- 2014-03-14 WO PCT/US2014/028169 patent/WO2014143964A2/en not_active Ceased
- 2014-03-14 US US14/775,584 patent/US9655867B2/en active Active
- 2014-03-14 CA CA3179312A patent/CA3179312C/en active Active
-
2017
- 2017-05-03 US US15/585,932 patent/US10071065B2/en active Active
-
2018
- 2018-05-04 US US15/971,781 patent/US10507189B2/en active Active
- 2018-11-15 AU AU2018264078A patent/AU2018264078B2/en active Active
-
2019
- 2019-09-09 US US16/564,649 patent/US10688062B2/en active Active
- 2019-11-07 JP JP2019202439A patent/JP2020037574A/ja active Pending
-
2020
- 2020-05-08 US US16/869,797 patent/US11304913B2/en active Active
- 2020-08-19 AU AU2020220122A patent/AU2020220122A1/en not_active Abandoned
-
2021
- 2021-12-28 JP JP2021213648A patent/JP7410114B2/ja active Active
-
2022
- 2022-06-13 AU AU2022204105A patent/AU2022204105A1/en not_active Abandoned
-
2023
- 2023-12-21 JP JP2023215692A patent/JP2024026453A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020037574A5 (https=) | ||
| JP2016513727A5 (https=) | ||
| JP7410114B2 (ja) | 新規な鎮痛組成物 | |
| US11197852B2 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| JP4275751B2 (ja) | 外用組成物 | |
| EP3087985B1 (en) | Hydrous adhesive patch | |
| EP0375689B1 (en) | A pharmaceutical composition adapted for transdermal delivery of an opoid drug. | |
| BRPI0618891A2 (pt) | composições farmacêuticas | |
| JP2016529328A (ja) | 舌下ブプレノルフィンスプレー | |
| CN103889508A (zh) | 用于传递丁丙诺啡的防滥用性粘膜粘附剂装置 | |
| JPH02191215A (ja) | ブプレノルフイン塩類の経皮デリバリー用組成物 | |
| CN110022864B (zh) | 用于治疗睡眠障碍的经皮吸收制剂 | |
| PT1811995E (pt) | Composição veterinária transmucosa compreendendo detomidina | |
| US10307381B2 (en) | Patch | |
| KR20190092313A (ko) | 경피 흡수형 제제 | |
| EP2829272B1 (en) | Transdermal absorption preparation | |
| TWI544924B (zh) | 經皮吸收製劑 | |
| US20230218538A1 (en) | Transdermal patch | |
| JP6865235B2 (ja) | ブトルファノール含有貼付剤 | |
| CA2946434C (en) | Transdermal formulations of pergolide and uses thereof | |
| KR101564538B1 (ko) | 동물용 복합항생제 조성물 | |
| JP7802471B2 (ja) | 貼付剤、貼付剤の製造方法、加水分解抑制剤、及び加水分解抑制方法 | |
| US20190022024A1 (en) | Transdermal patch | |
| TW201332592A (zh) | 經皮吸收型製劑 | |
| JP2014505727A (ja) | フェンタニルの経皮溶液を使用してウマ科動物において疼痛を抑制するための方法 |